<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03658083</url>
  </required_header>
  <id_info>
    <org_study_id>228/16</org_study_id>
    <nct_id>NCT03658083</nct_id>
  </id_info>
  <brief_title>Exploring Robotic-assisted Thoracic Surgery for Lung Cancer</brief_title>
  <acronym>ROSE</acronym>
  <official_title>Exploring Robotic-assisted Thoracic Surgery for Lung Cancer: Does Robotic-assisted Thoracic Surgery Result in Improved Functional Outcomes Compared to Thoracotomy and How do Patients Appraise the Experience of Undergoing RATS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Teesside University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South Tees Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Teesside University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background Surgery for lung cancer can be performed using open (thoracotomy) or minimally&#xD;
      invasive techniques (Video Assisted Thoracic Surgery (VATS)). Despite being associated with&#xD;
      fewer postoperative complications (PPCs) VATS is difficult to perform and is only used by&#xD;
      20-44% of thoracic surgeons in the UK. Robotic-Assisted Thoracic Surgery (RATS) maybe a more&#xD;
      attractive minimally invasive approach. To date, no studies have explored the impact of RATS&#xD;
      on exercise capacity or physical activity and although 1 study has looked at Heath Related&#xD;
      Quality of Life (HRQOL) post-RATS compared to an open technique indicators of surgical&#xD;
      technique were not controlled for. Furthermore, investigators have little understanding of&#xD;
      patients' experience of RATS.&#xD;
&#xD;
      Aims&#xD;
&#xD;
        1. To examine the variability of change in exercise capacity and health-related quality of&#xD;
           life (HRQOL) between those who receive thoracotomy V RATS.&#xD;
&#xD;
        2. To compare the difference in post-operative physical activity (step and activity count),&#xD;
           across 7 days, in those who receive thoracotomy V RATS.&#xD;
&#xD;
        3. To explore the manner in which patients appraise their experience of undergoing RATS.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      A mixed-method, multi-center study will be undertaken, utilizing a prospective&#xD;
      quasi-experimental study design and an interpretive phenomenological approach. 80&#xD;
      individuals, referred for a lung lobectomy with a primary or secondary diagnosis of lung&#xD;
      cancer, will complete outcomes assessed at 4 time-points. The Incremental Shuttle Walk Test&#xD;
      (ISWT) and the European Organization for Research and Treatment of Cancer Quality of Life&#xD;
      Questionnaire (EORTC QLQ C30) and the EORTC Lung Cancer module (EORTC QLQ LC13) will be&#xD;
      completed at: baseline, 3-6 days post surgery, 6-weeks post-surgery and at 3-month follow up.&#xD;
      Patients will wear an activity monitor immediately post-surgery until 1-week post-discharge.&#xD;
      Step and activity counts will be recorded. In-depth interviews will be conducted with up to&#xD;
      15 patients who underwent RATS to explore the manner in which patients appraise their&#xD;
      experience of RATS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung cancer is the second most common cause of cancer in the UK and the most common cause of&#xD;
      cancer death. Surgery is currently the most effective treatment for curing lung cancer and it&#xD;
      can be performed using open (thoracotomy) or minimally invasive techniques (Video Assisted&#xD;
      Thoracic Surgery (VATS)). Despite VATS being associated with fewer postoperative&#xD;
      complications (PPCs), faster recovery and better survival at 4 years compared to thoracotomy&#xD;
      it is only used by 20-44% of thoracic surgeons in the UK and just 5% of surgeons in Europe&#xD;
      report using minimally invasive techniques for lung resection. Rigid, restrictive instruments&#xD;
      and suboptimal vision means a steep learning curve is necessary to conduct VATS successfully.&#xD;
      RATS maybe a more attractive minimally invasive approach as it offers 3DHD vision, a 360&#xD;
      degree view of the chest, and a fully articulated arm. JCUH and the Barts Hospital are two of&#xD;
      the few centers in the UK performing RATS.&#xD;
&#xD;
      Research on RATS has been largely limited to single retrospective case series reports&#xD;
      focusing on safety (PPCs and mortality) and cost effectiveness outcomes. Little research has&#xD;
      been conducted exploring the effect of RATS on patient-centered outcomes that are also&#xD;
      important quality measures.&#xD;
&#xD;
      To date, no studies have explored the impact of RATS on exercise capacity, yet investigators&#xD;
      know that individuals who undergo a thoracotomy have a 16% reduction in exercise capacity at&#xD;
      6 months follow up. Exercise capacity has been shown to be an important predictor for&#xD;
      long-term prognosis and length of stay following thoracic surgery, which can have substantial&#xD;
      implications for cost. Furthermore, percentage VO2 max has been shown to be the best&#xD;
      predictor of PPCs within 30 days of undergoing a lung resection (predictive value 85.5%),&#xD;
      which is an important indicator of patient safety.&#xD;
&#xD;
      Two studies have looked at HRQOL post-RATS and compared it to an open technique. Balduyck and&#xD;
      colleagues reported that whilst significant reductions from baseline were seen 1 month&#xD;
      post-surgery in those who underwent an open procedure (sternotomy), HRQOL had returned to&#xD;
      baseline values by 1 month post-surgery in those who underwent RATS. However, indicators of&#xD;
      whether individuals received RATS or an open procedure were not controlled for which is&#xD;
      likely to be important as individuals who have large tumors are not eligible to receive RATS.&#xD;
      Instead RATS is usually assigned to older, frailer individuals. The second study did conduct&#xD;
      between-groups comparisons between those who underwent a robotic lobectomy V those who&#xD;
      received an open rib and nerve sparing lobectomy. The mental-component of the SF-12 was&#xD;
      significantly higher in the robot group at 3 weeks post-surgery, indicating better mental&#xD;
      quality of life, although there were no significant between-group differences detected for&#xD;
      the physical-component. By 4 months follow up neither the mental nor the physical HRQOL&#xD;
      scores differed between the two groups. The SF-12 in a general measure of health status and&#xD;
      to date the impact of open surgery V RATS on disease-specific HRQOL has not been explored.&#xD;
&#xD;
      Physical activity is associated with improved HRQOL in patients with lung cancer and&#xD;
      increased survival post-diagnosis of cancer. However, 2 months following a lung resection,&#xD;
      performed via a thoracotomy or VATS, physical activity levels were still reduced.&#xD;
      Unfortunately comparisons between surgical groups were not possible in this study due to the&#xD;
      small number of patients who underwent VATS (14), therefore postoperative physical activity&#xD;
      in those who have undergone thoracotomy compared to minimally invasive surgery is still&#xD;
      unknown.&#xD;
&#xD;
      Clinical Commissioning Group (CCG) outcome indicator set 2015/16 includes enhancing quality&#xD;
      of life and ensuring patients have a positive experience of care (NHS England, 2015). To&#xD;
      date, no qualitative research exploring the patients' experience of RATS has been conducted&#xD;
      and investigators have little understanding of patients' experience of thoracic surgery in&#xD;
      general. Interestingly, a very recent study exploring preoperative nurses work experience&#xD;
      with robotics found that feelings of uncertainty and concerns about safety were common due to&#xD;
      a lack of education about the robot system. It is likely, these feelings of unease are&#xD;
      translated to patients during their preoperative consultation leading to heightened anxiety.&#xD;
      Furthermore, if nurses do not feel they have sufficient information about the robot system&#xD;
      they are unlikely to be educating patients fully about their procedure. A study exploring the&#xD;
      appraisals of patients' experience of RATS is important to identify ways in which both pre&#xD;
      and postoperative care can be improved.&#xD;
&#xD;
      It would seem literature is scare exploring the impact of RATS on outcomes that are likely to&#xD;
      be meaningful to patients. Therefore the overall aim of this study is to examine the impact&#xD;
      of RATS compared to thoracotomy on patient-centered outcomes and to explore the individuals'&#xD;
      experience of undergoing RATS.&#xD;
&#xD;
      Research strategy&#xD;
&#xD;
      Study design&#xD;
&#xD;
      A mixed-method, multi-center study will be undertaken, utilizing a prospective&#xD;
      quasi-experimental study design and an interpretive phenomenological approach.&#xD;
&#xD;
      Inclusion/exclusion criteria&#xD;
&#xD;
      Individuals referred for a lung resection with a primary or secondary diagnosis of lung&#xD;
      cancer will be eligible, although those with a tumor &gt;7cm will be excluded. Individuals&#xD;
      referred for a lung resection via thoracotomy will be recruited from James Cook University&#xD;
      Hospital (JCUH), Middlesbrough and those referred for RATS will be recruited from JCUH or St&#xD;
      Bartholomew's hospital, London (Barts).&#xD;
&#xD;
      Recruitment&#xD;
&#xD;
      Once a referral for a lung resection via thoracotomy or RATS is received a cover letter and&#xD;
      information sheet, containing details of the study, will be mailed to patients along with&#xD;
      their clinic appointment letter. Interested patients will be encouraged to contact a member&#xD;
      of the research team, by telephone or email, to discuss the study in more detail. When&#xD;
      patients attend their preoperative clinic a member of the clinical team will request&#xD;
      permission for a member of the research team to approach them about participation in the&#xD;
      study. If individuals would like to participate in the study informed consent will be&#xD;
      obtained.&#xD;
&#xD;
      Surgical care&#xD;
&#xD;
      Prior to surgery all patients receive standard physiotherapy consisting of breathing&#xD;
      exercises and advice on activities postoperatively.&#xD;
&#xD;
      Three cardiothoracic surgeons, 2 at JCUH and 1 at Barts, will perform lung resections.&#xD;
&#xD;
      Consistent with usual care at JCUH and Barts all individuals will be transferred to sitting&#xD;
      at the bedside as soon as possible post-surgery and will be required to walk 150m before&#xD;
      being discharged home. At JCUH patients are also required to complete a flight of stairs and&#xD;
      cycle for five minutes (with no resistance).&#xD;
&#xD;
      Data collection&#xD;
&#xD;
      Demographic and anthropometric information will be collected at baseline at the preoperative&#xD;
      clinic visit including; age, sex, BMI, lung function (forced expiratory volume in one second&#xD;
      (FEV1) and forced vital capacity (FVC)), smoking history, comorbidities, cancer stage and&#xD;
      grade. Details of the operation (i.e. technique, time, surgeon, post-operative pain&#xD;
      management) will be documented. Length of stay, readmissions and PPCs will be recorded at 3&#xD;
      months follow-up. The same criteria will be used to define a PPC as applied by Brocki et al.&#xD;
      PPCs will be classified as minor (a score of 1), medium (a score of two) or severe (a score&#xD;
      of three). A PPC will be defined as clinically relevant if two or more items are graded as a&#xD;
      minor complication (score of 1) or one item is graded as a medium or severe complication&#xD;
      (scores â‰¥2).&#xD;
&#xD;
      Quantitative phase&#xD;
&#xD;
      Outcomes will be assessed at 4 time-points; at baseline in the preoperative clinic (1 day to&#xD;
      2 weeks prior to surgery), day 3 post-surgery, at the follow up postoperative clinic visit&#xD;
      (within 6 weeks post-surgery) and at an additional hospital visit which will take place at 3&#xD;
      months. The time taken to complete each assessment will be recorded, we estimate no more than&#xD;
      2 hours will be required to complete the outcome variables (ISWT, the European Organization&#xD;
      for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30) and the&#xD;
      EORTC Lung Cancer module (EORTC QLQ LC13)). Individuals will also be requested to wear an&#xD;
      activity monitor Actigraph G3TX (Actigraph) immediately post-surgery until 1-week&#xD;
      post-discharge. Data will be stored on the cardiothoracic database at JCUH or Barts and on an&#xD;
      IBM SPSS statistics database at Teesside University.&#xD;
&#xD;
      Qualitative phase&#xD;
&#xD;
      An interpretive phenomenological approach (IPA) will be applied to the collection and&#xD;
      analysis of the qualitative data. IPA aims to understand the lived experience of participants&#xD;
      in response to a specific event (i.e. undergoing surgery). Analysis examines in detail how an&#xD;
      event is experienced and what meaning is ascribed to that event.&#xD;
&#xD;
      An informal interview schedule consisting of open-ended questions will be developed in&#xD;
      conjunction with members of the cardiothoracic team. The questions will be developed to&#xD;
      stimulate narratives focusing on the experience of undergoing RATS whilst also permitting&#xD;
      other topics, important to the individuals, to be discussed.&#xD;
&#xD;
      In-depth interviews will be conducted on up to 15 patients who underwent RATS. The interviews&#xD;
      will be conducted at patient's homes one week following hospital discharge (at the same time&#xD;
      the activity monitor is collected). Interviews will be largely patient led, allowing&#xD;
      individuals to tell their own story in their own words and at their own pace.&#xD;
&#xD;
      Sample Size and Analysis Plan&#xD;
&#xD;
      Quantitative phase&#xD;
&#xD;
      The primary endpoint is exercise capacity measured by the ISWT (m) completed at patients'&#xD;
      6-week postoperative clinic. Based on the minimal clinically important difference (MCID)&#xD;
      (48m) for the ISWT (Singh et al 2008), the between-subjects variability in the measure, and&#xD;
      the variability in the change scores (the 7-week reliability). A conventional estimation with&#xD;
      90% power and 2 p=0.05 returned a required sample size of 80 patients, 40 per group. This is&#xD;
      based on an ANCOVA analysis model, where invetigators look at the differences in the change&#xD;
      in ISWT between groups, adjusted for any imbalance between groups in ISWT performance at&#xD;
      baseline&#xD;
&#xD;
      Qualitative phase&#xD;
&#xD;
      Analysis will involve conducting a close line-by-line analysis on each original transcript to&#xD;
      explore the claims and understandings of the participants. A second researcher will review&#xD;
      the original transcripts before the 'emerging themes' are agreed. Once agreed, 2 researchers&#xD;
      will transfer the 'emerging themes' across the entire data set, thereafter referring to them&#xD;
      as 'master themes' The final master themes will be presented to a third researcher and&#xD;
      agreed. Thematic mapping will be used to develop the relationship between themes. Finally,&#xD;
      the findings will be translated into a narrative account with verbatim extracts (quotes) to&#xD;
      provide a means of validation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">October 12, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in exercise capacity assessed using the Incremental Shuttle Walk Test (ISWT)</measure>
    <time_frame>Baseline to 4-6 weeks post-surgery (visit 2)</time_frame>
    <description>Distance walked in meters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in physical activity assessed using an Activity Monitor</measure>
    <time_frame>Immediately post-surgery to 1-week post-discharge</time_frame>
    <description>Actigraph G3TX. Activity counts will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in health related quality of life assessed using self-reported questionnaire</measure>
    <time_frame>Baseline to 3-6 days post-surgery (visit 1)</time_frame>
    <description>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in disease-specific health related quality of life assess using a self-reported questionnaire</measure>
    <time_frame>Baseline to 3-6 days post-surgery (visit 1)</time_frame>
    <description>European Organization for Reseach and Treatment of Cancer Quality of Life - Lung Cancer module (EORTC QLQ LC13)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Health related quality of life assessed using self-reported questionnaire</measure>
    <time_frame>Baseline to 4-6 weeks post-surgery (visit 2)</time_frame>
    <description>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in disease-specific health related quality of life assessed using self-reported questionnaire</measure>
    <time_frame>Baseline to 4-6 weeks post-surgery (visit 2)</time_frame>
    <description>European Organization for Reseach and Treatment of Cancer Quality of Life - Lung Cancer module (EORTC QLQ LC13)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in health related quality of life assessed using self-reported questionnaire</measure>
    <time_frame>Baseline to 3 month post-surgery (visit 3)</time_frame>
    <description>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in disease-specific health related quality of lifeassessed using self-reported questionnaire</measure>
    <time_frame>Baseline to 3 month post-surgery (visit 3)</time_frame>
    <description>European Organization for Reseach and Treatment of Cancer Quality of Life - Lung Cancer module (EORTC QLQ LC13)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise capacity assessed using the Incremental Shuttle Walk Test (ISWT)</measure>
    <time_frame>Baseline to 3-6days post-surgery (visit 1).</time_frame>
    <description>Distance walked in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise capacity assessed using the Incremental Shuttle Walk Test (ISWT)</measure>
    <time_frame>Baseline to 3 months post-surgery (visit 3)</time_frame>
    <description>Distance walked in meters</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>3month follow up</time_frame>
    <description>Days in hospital post-surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital readmissions</measure>
    <time_frame>3month follow up</time_frame>
    <description>Number of times readmitted to hospital following discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>Post-operative pulmonary complications</measure>
    <time_frame>3month follow up</time_frame>
    <description>Based on criteria applied by Brocki et al. Classified as minor, medium or severe</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">131</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Thoracic Cancer</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Thoracotomy</arm_group_label>
    <description>Individuals referred for a lung resection via thoracotomy with a primary or secondary diagnosis of lung cancer. Those with a tumor &gt;7cm will be excluded.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Robotic-assisted thoracic surgery</arm_group_label>
    <description>Individuals referred for a lung resection via robotic-assisted thoracic surgery with a primary or secondary diagnosis of lung cancer. Those with a tumor &gt;7cm will be excluded.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracotomy</intervention_name>
    <description>Open surgery</description>
    <arm_group_label>Thoracotomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic-assisted thoracic surgery</intervention_name>
    <description>Minimally invasive surgery</description>
    <arm_group_label>Robotic-assisted thoracic surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals referred for a lung resection with a primary or secondary diagnosis of lung&#xD;
        cancer will be eligible, although those with a tumor &gt;7cm will be excluded. Individuals&#xD;
        referred for a lung resection via thoracotomy will be recruited from James Cook University&#xD;
        Hospital and those referred for RATS will be recruited from James Cook University Hospital&#xD;
        or the Barts Health.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals referred for a lung resection via thoracotomy or RATS with a primary or&#xD;
             secondary diagnosis of lung cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Tumor &gt;7cm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Samantha Harrison</last_name>
    <role>Principal Investigator</role>
    <affiliation>Teesside University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samantha Harrison</last_name>
    <phone>01642 738412</phone>
    <email>S.L.Harrison@tees.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barts Health NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Stamenkovic</last_name>
      <phone>020 7370 700</phone>
      <email>Steven.Stamenkovic@bartshealth.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Dunning</last_name>
      <phone>01642 854612</phone>
      <email>joeldunning@nhs.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2018</study_first_posted>
  <last_update_submitted>September 16, 2019</last_update_submitted>
  <last_update_submitted_qc>September 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Teesside University</investigator_affiliation>
    <investigator_full_name>Samantha Harrison</investigator_full_name>
    <investigator_title>Reader in research</investigator_title>
  </responsible_party>
  <keyword>exercise</keyword>
  <keyword>physical activity</keyword>
  <keyword>quality of life</keyword>
  <keyword>qualitative</keyword>
  <keyword>recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

